Computational platform for drug discovery/development
HBM contact: Dr Andreas Wicki
Company status: private
Valo created an active-learning integrated
drug discovery and development engine, spanning the entire R&D lifecycle.
Valo’s platform has the potential to deliver breakthrough medicines at far less
cost and with fewer failures. In doing so it combines data unrivaled in size,
depth and fidelity with real-world evidence, human insights, and machine
learning to feed an integrated system driven by massive compute power. Valo identifies molecules and predicts
their chances for success for the right patient populations at an unprecedented
pace.